JOHNSON & JOHNSON (JNJ) Marketable Securities, Current USD 2014 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of investment in marketable security, classified as current.
Summary
Johnson & Johnson quarterly Marketable Securities, Current history and growth rate from 2014 to 2024.
  • Johnson & Johnson Marketable Securities, Current for the quarter ending March 31, 2024 was $745M, a 86.3% decline year-over-year.
Marketable Securities, Current, Quarterly Data (USD)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 $745M -$4.7B -86.3% Mar 31, 2024 10-Q 2024-05-01
Q4 2023 $1.07B -$8.32B -88.6% Dec 31, 2023 10-Q 2024-05-01
Q3 2023 $3.78B -$18.9B -83.4% Oct 1, 2023 10-Q 2023-10-27
Q2 2023 $7.32B -$14.3B -66.1% Jul 2, 2023 10-Q 2023-07-31
Q1 2023 $5.44B -$14.5B -72.7% Apr 2, 2023 10-Q 2023-04-28
Q4 2022 $9.39B -$7.73B -45.1% Jan 1, 2023 10-K 2024-02-16
Q3 2022 $22.7B +$9.33B +69.6% Oct 2, 2022 10-Q 2022-10-27
Q2 2022 $21.6B +$10.6B +96.7% Jul 3, 2022 10-Q 2022-07-29
Q1 2022 $19.9B +$7.98B +66.8% Apr 3, 2022 10-Q 2022-04-29
Q4 2021 $17.1B +$5.92B +52.9% Jan 2, 2022 10-K 2023-02-16
Q3 2021 $13.4B +$1.58B +13.4% Oct 3, 2021 10-Q 2021-10-29
Q2 2021 $11B +$3.01B +37.8% Jul 4, 2021 10-Q 2021-07-29
Q1 2021 $11.9B +$9.45B +379% Apr 4, 2021 10-Q 2021-04-30
Q4 2020 $11.2B +$9.22B +465% Jan 3, 2021 10-K 2022-02-17
Q3 2020 $11.8B +$10.1B +597% Sep 27, 2020 10-Q 2020-10-23
Q2 2020 $7.96B +$7.06B +783% Jun 28, 2020 10-Q 2020-07-24
Q1 2020 $2.49B +$1.89B +314% Mar 29, 2020 10-Q 2020-04-29
Q4 2019 $1.98B +$402M +25.4% Dec 29, 2019 10-K 2021-02-22
Q3 2019 $1.7B -$1.61B -48.7% Sep 29, 2019 10-Q 2019-10-28
Q2 2019 $902M +$332M +58.2% Jun 30, 2019 10-Q 2019-07-29
Q1 2019 $602M +$37M +6.55% Mar 31, 2019 10-Q 2019-05-01
Q4 2018 $1.58B +$1.11B +235% Dec 30, 2018 10-K 2020-02-18
Q3 2018 $3.31B +$2.8B +549% Sep 30, 2018 10-Q 2018-10-31
Q2 2018 $570M +$315M +124% Jul 1, 2018 10-Q 2018-08-02
Q1 2018 $565M -$17.9B -96.9% Apr 1, 2018 10-Q 2018-05-01
Q4 2017 $472M -$22.5B -97.9% Dec 31, 2017 10-K 2019-02-20
Q3 2017 $510M -$21.7B -97.7% Oct 1, 2017 10-Q 2017-11-02
Q2 2017 $255M -$23.7B -98.9% Jul 2, 2017 10-Q 2017-08-03
Q1 2017 $18.4B -$7.56B -29.1% Apr 2, 2017 10-Q 2017-05-08
Q4 2016 $22.9B -$1.71B -6.94% Jan 1, 2017 10-K 2018-02-21
Q3 2016 $22.2B -$1.44B -6.08% Oct 2, 2016 10-Q 2016-11-04
Q2 2016 $23.9B +$629M +2.7% Jul 3, 2016 10-Q 2016-08-04
Q1 2016 $26B +$6.66B +34.5% Apr 3, 2016 10-Q 2016-05-10
Q4 2015 $24.6B +$6.08B +32.7% Jan 3, 2016 10-K 2017-02-27
Q3 2015 $23.7B Sep 27, 2015 10-Q 2015-10-30
Q2 2015 $23.3B Jun 28, 2015 10-Q 2015-07-31
Q1 2015 $19.3B Mar 29, 2015 10-Q 2015-05-01
Q4 2014 $18.6B Dec 28, 2014 10-K 2016-02-24
* An asterisk sign (*) next to the value indicates that the value is likely invalid.